company background image
HVO logo

hVIVO AIM:HVO Stock Report

Last Price

UK£0.18

Market Cap

UK£123.3m

7D

2.9%

1Y

-34.5%

Updated

16 May, 2025

Data

Company Financials +

hVIVO plc

AIM:HVO Stock Report

Market Cap: UK£123.3m

HVO Stock Overview

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. More details

HVO fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 70.5% below our estimate of its fair value

Earnings are forecast to grow 6.18% per year

Trading at good value compared to peers and industry

Risk Analysis

Profit margins (16.1%) are lower than last year (27.5%)


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

HVO logo
hVIVO
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts

Canary Wharf Expansion And Automation Will Improve Efficiency Despite Risks

Key Takeaways hVIVO's operational enhancements and facility expansions aim to boost efficiency and trial capacity, potentially driving revenue and margin growth. Diversification and strategic integrations are set to enhance service offerings, reduce dependency, and strengthen long-term revenue opportunities.
View narrative
UK£0.32
FV
44.2% undervalued intrinsic discount
10.10%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
16 days ago author updated this narrative
View hVIVO Community

hVIVO plc Competitors

Bioventix

AIM:BVXP

UK£146.3m

Animalcare Group

AIM:ANCR

UK£169.0m

ECO Animal Health Group

AIM:EAH

UK£42.3m

Genovis AB (publ.)

OM:GENO

SEK 1.6b

Price History & Performance

Summary of share price highs, lows and changes for hVIVO
Historical stock prices
Current Share PriceUK£0.18
52 Week HighUK£0.31
52 Week LowUK£0.13
Beta1.34
1 Month Change8.27%
3 Month Change0%
1 Year Change-34.55%
3 Year Change25.44%
5 Year Change26.32%
Change since IPO164.71%

Recent News & Updates

author-image

Expansion Into New Canary Wharf Facility Will Increase Capacity But Challenges In Sustaining Margins May Arise

Feb 09 Expansion into a new facility and offering new services are expected to drive revenue growth and diversify income streams.

Recent updates

author-image

Expansion Into New Canary Wharf Facility Will Increase Capacity But Challenges In Sustaining Margins May Arise

Feb 09 Expansion into a new facility and offering new services are expected to drive revenue growth and diversify income streams.

hVIVO plc's (LON:HVO) Intrinsic Value Is Potentially 28% Above Its Share Price

Jan 26
hVIVO plc's (LON:HVO) Intrinsic Value Is Potentially 28% Above Its Share Price

Improved Revenues Required Before hVIVO plc (LON:HVO) Stock's 26% Jump Looks Justified

Jan 03
Improved Revenues Required Before hVIVO plc (LON:HVO) Stock's 26% Jump Looks Justified

At UK£0.20, Is hVIVO plc (LON:HVO) Worth Looking At Closely?

Nov 30
At UK£0.20, Is hVIVO plc (LON:HVO) Worth Looking At Closely?

A Piece Of The Puzzle Missing From hVIVO plc's (LON:HVO) Share Price

Jun 14
A Piece Of The Puzzle Missing From hVIVO plc's (LON:HVO) Share Price

A Look At The Intrinsic Value Of hVIVO plc (LON:HVO)

Feb 01
A Look At The Intrinsic Value Of hVIVO plc (LON:HVO)

Should You Investigate hVIVO plc (LON:HVO) At UK£0.11?

Dec 20
Should You Investigate hVIVO plc (LON:HVO) At UK£0.11?

Is There An Opportunity With Open Orphan Plc's (LON:ORPH) 41% Undervaluation?

Sep 13
Is There An Opportunity With Open Orphan Plc's (LON:ORPH) 41% Undervaluation?

Are Investors Undervaluing Open Orphan plc (LON:ORPH) By 44%?

Jun 02
Are Investors Undervaluing Open Orphan plc (LON:ORPH) By 44%?

Introducing Open Orphan (LON:ORPH), The Stock That Soared 388% In The Last Year

Feb 15
Introducing Open Orphan (LON:ORPH), The Stock That Soared 388% In The Last Year

How Much Of Open Orphan plc (LON:ORPH) Do Insiders Own?

Dec 23
How Much Of Open Orphan plc (LON:ORPH) Do Insiders Own?

Calculating The Fair Value Of Open Orphan plc (LON:ORPH)

Nov 18
Calculating The Fair Value Of Open Orphan plc (LON:ORPH)

Shareholder Returns

HVOGB Life SciencesGB Market
7D2.9%-3.4%1.4%
1Y-34.5%-13.4%0.02%

Return vs Industry: HVO underperformed the UK Life Sciences industry which returned -13.4% over the past year.

Return vs Market: HVO underperformed the UK Market which returned 0% over the past year.

Price Volatility

Is HVO's price volatile compared to industry and market?
HVO volatility
HVO Average Weekly Movement7.4%
Life Sciences Industry Average Movement7.1%
Market Average Movement5.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market3.2%

Stable Share Price: HVO has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: HVO's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a301Mo Khanwww.hvivo.com

hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in testing of vaccines and antivirals using human challenge clinical trials; and offers laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker analysis services. It has a portfolio of human challenge study models for conditions, such as RSV, influenza, COVID-19, hMPV, HRV, asthma, malaria, and COPD.

hVIVO plc Fundamentals Summary

How do hVIVO's earnings and revenue compare to its market cap?
HVO fundamental statistics
Market capUK£123.32m
Earnings (TTM)UK£10.65m
Revenue (TTM)UK£66.22m

11.5x

P/E Ratio

1.8x

P/S Ratio

Is HVO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HVO income statement (TTM)
RevenueUK£66.22m
Cost of RevenueUK£49.80m
Gross ProfitUK£16.42m
Other ExpensesUK£5.76m
EarningsUK£10.65m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.016
Gross Margin24.79%
Net Profit Margin16.09%
Debt/Equity Ratio0%

How did HVO perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

13%

Payout Ratio

Does HVO pay a reliable dividends?

See HVO dividend history and benchmarks
When do you need to buy HVO by to receive an upcoming dividend?
hVIVO dividend dates
Ex Dividend DateMay 15 2025
Dividend Pay DateJun 11 2025
Days until Ex dividend2 days
Days until Dividend pay date25 days

Does HVO pay a reliable dividends?

See HVO dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 21:42
End of Day Share Price 2025/05/16 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

hVIVO plc is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew SimmsArden Partners Plc.
Michael MitchellCavendish
Edward ThomasonCGS International